Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

Ro 10-9359 is an effective treatment for severe psoriasis but can cause side effects.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Topical ruxolitinib quickly improves non-segmental vitiligo.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Prescription tablets treat hirsutism, while over-the-counter foams treat hypertrichosis.

The new ddPCR method reliably detects unwanted viruses in CAR-T cell products, ensuring their safety for patients.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Gluconolactone products can significantly reduce skin scaling in golden retrievers with ARCI.

Anti-TNF therapy can cause hair loss and skin issues.

The PCL/PHB blend allows for slower, more controlled curcumin release than individual polymers.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

Baricitinib is effective and safe for treating severe alopecia areata.

Tph cells are linked to the severity of systemic lupus erythematosus.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Standardized definitions and better methods are needed to accurately estimate long COVID-19 prevalence.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

The new gel effectively treats psoriasis with minimal side effects.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

The method accurately measures cyproterone acetate in plasma, showing no significant difference between two formulations.

Baricitinib can lead to hair regrowth in alopecia areata but may also cause relapses.

A woman with both Cronkhite-Canada syndrome and myelodysplastic syndrome improved significantly with corticosteroid treatment.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Aumolertinib effectively controls lung cancer and improves quality of life.

Low-dose isotretinoin combined with pulsed azithromycin cleared acne in most patients, with mild side effects.